Park Medi World Q2 Results: Stock falls 8% after profit, margins come under pressure

Résumé détaillé

Park Medi World's Earnings before interest, taxes, depreciation and amortization (EBITDA) declined by 9.5% during the quarter to ₹101.8 crore from ₹112.5 crore in the corresponding quarter in the previous fiscal.

Shares of Park Medi World Ltd. fell sharply by nearly 8% on Friday, November 13, after the company reported a weak set of earnings for the second quarter.

Barring its revenue, Park Medi World's earnings declined across the other key parameters on a year-on-year basis.

For the September quarter, Park Medi World's revenue of ₹511 crore grew by 24.6% from ₹410 crore it reported during the second quarter last year. The company said it saw its highest-ever revenue in any three month period.

Net profit fell 29.7% to ₹52 crore in the September quarter from ₹74 crore during the year-ago quarter.

Earnings before interest, taxes, depreciation and amortization (EBITDA) declined by 9.5% during the quarter to ₹101.8 crore from ₹112.5 crore in the corresponding quarter in the previous fiscal.

The company's EBITDA margin contracted sharply by 740 basis points to 20% from 27.4% in the year-ago period.

The company said it treated 2.90 lakh patients in the second quarter, its highest-ever in any three-month period.

The company's chairman Ajit Gupta and managing director Ankit Gupta in a joint statement said the company added 680 beds in just six months through Rudrapur and Panchkula, taking its capacity to 4,290 beds. They said that as expected, onboarding this new capacity has had a near-term bearing on occupancy and profitability, as new facilities take time to ramp up.

With the commissioning of Febris (Delhi), the Palam Vihar expansion (Gurugram), Mehar Hospital (Zikrapur) and the Kanpur facility, the company expects the total additions of 1,430 beds in the financial year 2027, 40% over its Fy26 closing capacity and the largest addition ever in its history.

Début de l'article, extrait de CNBC-TV18. Pour lire la suite, ouvrez l'article chez le média.